Sangamo Therapeutics
SGMO
$0.52
Share price
6.84%
Change (1 day)
-67.40%
Change (1 year)
Sangamo Therapeutics (SGMO) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $82.43 M
According to Sangamo Therapeutics 's latest financial reports the company's total liabilities are $82.43 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Sangamo Therapeutics - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $82.43 M | -69.19% |
| 2022-12-31 | $0.26 B | -22.8% |
| 2021-12-31 | $0.34 B | -21.44% |
| 2020-12-31 | $0.44 B | 115.45% |
| 2019-12-31 | $0.20 B | -8.23% |
| 2018-12-31 | $0.22 B | 125.75% |
| 2017-12-31 | $98.84 M | 355.57% |
| 2016-12-31 | $21.69 M | -12.5% |
| 2015-12-31 | $24.79 M | -32.21% |
| 2014-12-31 | $36.57 M | 91.23% |
| 2013-12-31 | $19.12 M | 8.45% |
| 2012-12-31 | $17.63 M | 144.82% |
| 2011-12-31 | $7.2 M | 1.58% |
| 2010-12-31 | $7.09 M | -54.7% |
| 2009-12-31 | $15.65 M | 25.72% |
| 2008-12-31 | $12.45 M | 5.74% |
| 2007-12-31 | $11.77 M | 66.47% |
| 2006-12-31 | $7.07 M | -36.66% |
| 2005-12-31 | $11.16 M | 375.68% |
| 2004-12-31 | $2.34 M | 49.46% |
| 2003-12-31 | $1.57 M | -20.7% |
| 2002-12-31 | $1.98 M | -25.75% |
| 2001-12-31 | $2.66 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 119,735.50% | 🇺🇸 USA |
 Amgen AMGN | $90.92 B | 110,198.06% | 🇺🇸 USA |
 Biogen BIIB | $12.04 B | 14,512.35% | 🇺🇸 USA |
 Dow DOW | $38.85 B | 47,040.10% | 🇺🇸 USA |
 Gilead Sciences GILD | $39.37 B | 47,667.28% | 🇺🇸 USA |
 Merck MRK | $69.04 B | 83,652.87% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $4.05 B | 4,813.71% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.89 B | 2,192.83% | 🇺🇸 USA |